TrialBritish journal of haematology2021

Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.

Max S Topp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.